Can Minimally Invasive Surgery Still Be Done for Cervical Cancer Patients Considering the LACC Trial?

Sichen Liang,Zhiqing Liang,Samar Nahas,Jianming Song,Zeyi Cao,Adel Shervin,Bruno J. van Herendael,Jennifer Song,Jianliu Wang
DOI: https://doi.org/10.1016/j.gocm.2021.11.002
2021-01-01
Gynecology and Obstetrics Clinical Medicine
Abstract:1.Background For the past several decades,minimally invasive surgery(MIS)has been advantageous for the treatment of cervical cancer compared to open surgery.MIS is favored due to reduced blood loss,decreased post-operative complications,rapid recovery,and shorter hospitalization time.In 2018,results from the Laparoscopic Approach to Cervical Cancer(LACC)trial,an international multicenter randomized phase Ⅲ trial of women with early-stage cervical cancer comparing the survival outcomes among different surgical approaches1 and a real-world study published in the New England Journal of Medicine,2 showed that patients with early-stage cervical cancer undergoing minimally invasive radical hys-terectomy have a lower rate of progression-free survival and overall survival(OS)than those who undergo an abdominal radical hysterec-tomy.As a result,the latest National Comprehensive Cancer Network(NCCN)guidelines no longer suggest minimally invasive radical hvster-ectomy,but rather open surgery as the standard approach.
What problem does this paper attempt to address?